Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Targeting EGFR for imaging and α-particle therapy

Diane Milenic, Martin Brechbiel, Kayhan Garmestani, Kwamena Baidoo, Celeste Reginoa, Karen Wong, Mark Williams, Michael Greene, Jurgen Seidel, Peter Choyke

Cancer Res (2008) 68 (9_Supplement): 3157.

Published: 01 May 2008

View articletitled, Targeting EGFR for imaging and α-particle therapy

Journal Articles

Targeting HER1 and HER2 using ⁸⁶Y-CHX-A” labeled cetuximab and trastuzumab for PET imaging

Celeste Regino, Diane Milenic, Karen Wong, Kayhan Garmestani, Kwamena Baidoo, Mark Williams, Jurgen Seidel, Michael Green, Peter Choyke, Martin Brechbiel

Cancer Res (2008) 68 (9_Supplement): 3159.

Published: 01 May 2008

View articletitled, Targeting HER1 and HER2 using 86Y-CHX-A” labeled cetuximab and trastuzumab for PET imaging

Journal Articles

Improved efficacy of α-particle radioimmunotherapy: targeting HER2 and TAG-72

Diane Milenic, Kayhan Garmestani, Erik Brady, Alia Abdulla, Martin Brechbiel

Cancer Res (2008) 68 (9_Supplement): 3158.

Published: 01 May 2008

View articletitled, Improved efficacy of α-particle radioimmunotherapy: targeting HER2 and TAG-72

Journal Articles

The Anti-CD25 Monoclonal Antibody 7G7/B6, Armed with the α-Emitter ²¹¹At, Provides Effective Radioimmunotherapy for a Murine Model of Leukemia

Meili Zhang, Zhengsheng Yao, Zhuo Zhang, Kayhan Garmestani, Vladimir S. Talanov, Paul S. Plascjak, Sarah Yu, Hyung-Sik Kim, Carolyn K. Goldman, Chang H. Paik, Martin W. Brechbiel, Jorge A. Carrasquillo, Thomas A. Waldmann

Cancer Res (2006) 66 (16): 8227–8232.

https://doi.org/10.1158/0008-5472.CAN-06-1189

Published: 15 August 2006

View articletitled, The Anti-CD25 Monoclonal Antibody 7G7/B6, Armed with the α-Emitter 211At, Provides Effective Radioimmunotherapy for a Murine Model of Leukemia

Journal Articles

Effective therapy of a murine model of anaplastic large cell lymphoma with an anti-CD30 monoclonal antibody, HeFi-1, armed with the alpha emitter, ²¹¹At.

Meili Zhang, Zhengsheng Yao, Hiral Patel, Zhuo Zhang, Kayhan Garmestani, Vladimir S. Talanov, Paul S. Plascjak, Carolyn K. Goldman, Martin W. Brechbiel, Thomas A. Waldmann

Cancer Res (2006) 66 (8_Supplement): 1349–1350.

Published: 15 April 2006

View articletitled, Effective therapy of a murine model of anaplastic large cell lymphoma with an anti-CD30 monoclonal antibody, HeFi-1, armed with the alpha emitter, 211At.

Journal Articles

Multimodality therapy: Potentiation of high-LET radiation with taxol for the treatment of disseminated peritoneal disease

Diane E. Milenic, Kayhan Garmestani, Erik D. Brady, Paul S. Albert, Alia Abdulla, Joseph Flynn, Martin W. Brechbiel

Cancer Res (2006) 66 (8_Supplement): 259–260.

Published: 15 April 2006

View articletitled, Multimodality therapy: Potentiation of high-LET radiation with taxol for the treatment of disseminated peritoneal disease

Journal Articles

Activating Fc Receptors Are Required for Antitumor Efficacy of the Antibodies Directed toward CD25 in a Murine Model of Adult T-Cell Leukemia

Meili Zhang, Zhuo Zhang, Kayhan Garmestani, Carolyn K. Goldman, Jeffrey V. Ravetch, Martin W. Brechbiel, Jorge A. Carrasquillo, Thomas A. Waldmann

Cancer Res (2004) 64 (16): 5825–5829.

https://doi.org/10.1158/0008-5472.CAN-04-1088

Published: 16 August 2004

View articletitled, Activating Fc Receptors Are Required for Antitumor Efficacy of the Antibodies Directed toward CD25 in a Murine Model of Adult T-Cell Leukemia

Journal Articles

Preclinical evaluation of an anti-CD25 monoclonal antibody armed with an alpha emitter, At-211, as a potential radioimmunotherapeutic agent for leukemia and lymphoma

Meili Zhang, Zhuo Zhang, Kayhan Garmestani, Hyung-Sik Kim, Carolyn K. Goldman, Chang Paik, Martin W. Brechbiel, Jorge A. Carrasquillo, Thomas A. Waldmann

Cancer Res (2004) 64 (7_Supplement): 956.

Published: 01 April 2004

View articletitled, Preclinical evaluation of an anti-CD25 monoclonal antibody armed with an alpha emitter, At-211, as a potential radioimmunotherapeutic agent for leukemia and lymphoma

Journal Articles

Radioimmunotherapy of A431 Xenografted Mice with Pretargeted B3 Antibody-Streptavidin and ⁹⁰Y-labeled 1,4,7,10-Tetraazacyclododecane- N,N′,N″,N‴ -tetraacetic Acid (DOTA)-Biotin

Zhengsheng Yao, Meili Zhang, Donald B. Axworthy, Karen J. Wong, Kayhan Garmestani, Luke Park, Chang W. Park, Robert W. Mallett, Louis J. Theodore, Eric K. Yau, Thomas A. Waldmann, Martin W. Brechbiel, Chang H. Paik, Ira Pastan, Jorge A. Carrasquillo

Cancer Res (2002) 62 (20): 5755–5760.

Published: 15 October 2002

View articletitled, Radioimmunotherapy of A431 Xenografted Mice with Pretargeted B3 Antibody-Streptavidin and 90Y-labeled 1,4,7,10-Tetraazacyclododecane- N,N′,N″,N‴ -tetraacetic Acid (DOTA)-Biotin

Journal Articles

Radioimmunotherapy of Nude Mice Bearing a Human Interleukin 2 Receptor α-expressing Lymphoma Utilizing the α-emitting Radionuclide-conjugated Monoclonal Antibody ²¹²Bi-anti-Tac

Frank Hartmann, Eva M. Horak, Kayhan Garmestani, Chuanchu Wu, Martin W. Brechbiel, Robert W. Kozak, J. Tso, Sheri A. Kosteiny, Otto A. Gansow, David L. Nelson, Thomas A. Waldmann

Cancer Res (1994) 54 (16): 4362–4370.

Published: 01 August 1994

View articletitled, Radioimmunotherapy of Nude Mice Bearing a Human Interleukin 2 Receptor α-expressing Lymphoma Utilizing the α-emitting Radionuclide-conjugated Monoclonal Antibody 212Bi-anti-Tac

Journal Articles

Preclinical Evaluation of ¹¹¹In-labeled B3 Monoclonal Antibody: Biodistribution and Imaging Studies in Nude Mice Bearing Human Epidermoid Carcinoma Xenografts

Luigi Camera, Seigo Kinuya, Lee H. Pai, Kayhan Garmestani, Martin W. Brechbiel, Otto A. Gansow, Chang H. Paik, Ira Pastan, Jorge A. Carrasquillo

Cancer Res (1993) 53 (12): 2834–2839.

Published: 01 June 1993

View articletitled, Preclinical Evaluation of 111In-labeled B3 Monoclonal Antibody: Biodistribution and Imaging Studies in Nude Mice Bearing Human Epidermoid Carcinoma Xenografts

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Targeting EGFR for imaging and α-particle therapy

Targeting HER1 and HER2 using ⁸⁶Y-CHX-A” labeled cetuximab and trastuzumab for PET imaging

Improved efficacy of α-particle radioimmunotherapy: targeting HER2 and TAG-72

The Anti-CD25 Monoclonal Antibody 7G7/B6, Armed with the α-Emitter ²¹¹At, Provides Effective Radioimmunotherapy for a Murine Model of Leukemia

Effective therapy of a murine model of anaplastic large cell lymphoma with an anti-CD30 monoclonal antibody, HeFi-1, armed with the alpha emitter, ²¹¹At.

Multimodality therapy: Potentiation of high-LET radiation with taxol for the treatment of disseminated peritoneal disease

Activating Fc Receptors Are Required for Antitumor Efficacy of the Antibodies Directed toward CD25 in a Murine Model of Adult T-Cell Leukemia

Preclinical evaluation of an anti-CD25 monoclonal antibody armed with an alpha emitter, At-211, as a potential radioimmunotherapeutic agent for leukemia and lymphoma

Radioimmunotherapy of A431 Xenografted Mice with Pretargeted B3 Antibody-Streptavidin and ⁹⁰Y-labeled 1,4,7,10-Tetraazacyclododecane- N,N′,N″,N‴ -tetraacetic Acid (DOTA)-Biotin

Radioimmunotherapy of Nude Mice Bearing a Human Interleukin 2 Receptor α-expressing Lymphoma Utilizing the α-emitting Radionuclide-conjugated Monoclonal Antibody ²¹²Bi-anti-Tac

Preclinical Evaluation of ¹¹¹In-labeled B3 Monoclonal Antibody: Biodistribution and Imaging Studies in Nude Mice Bearing Human Epidermoid Carcinoma Xenografts

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only